MENINGOCOCCAL INFECTIONS

Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth Edition

Volumn , Issue , 2009, Pages 1350-1366

  Anderson, Marsha S ^a,b   Glodé, Mary P ^a,b   Smith, Arnold L ^c,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

^c University of Washington School of Public Health   (United States)

^d SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051906370     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4044-6.50104-7     Document Type: Chapter

References (216)

1. L. Aiuto, S. Barone, P. Cohen, et al. (1997) Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans. Crit. Care Med. 25 1079.
2. American Academy of Pediatrics (2006) Red Book: Report on the Committee for Infectious Diseases 27th ed. Elk Grove Village, IL: American Academy of Pediatrics
3. Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. J. Infect. Dis. 134 201.
4. L. Argenbright and R. Barton (1992) Interactions of leukocyte integrins with intercellular adhesion molecule I in the production of inflammatory vascular injury in vivo. The Schwartzman reaction revisited. J. Clin. Invest. 89 259.
5. H. Banks (1948) Meningococcosis: A protean disease. Lancet 2 635.
6. M. Baraldes, P. Domingo, J. Barrio, et al. (2000) Meningitis due to Neisseria subflava: Case report and review. Clin. Infect. Dis. 30 615.
7. N. Barquet, I. Gasser, P. Domingo, et al. (1990) Primary meningococcal conjunctivitis: Report of 21 patients and review. Rev. Infect. Dis. 12 838.
8. F. Benoit (1963) Chronic meningococcemia. Medicine (Baltimore) 35 103.
9. G. Bernard, J. Vincent, P. Laterre, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344 699.
10. O.O. Bilukha and N. Rosenstein National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) (2005) Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). M. M. W. R. Recomm. Rep. 54(RR-7), 1.
11. G. Bjune, E.A. Hoiby, J.K. Gronnesby, et al. (1991) Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338 1093.
12. W. Boger (1944) Fulminating meningococcemia. N. Engl. J. Med. 231 385.
13. W. Boger (1944) Purulent meningococcal arthritis. Am. J. Med. Sci. 208 708.
14. P. Boisier, P. Nicolas, S. Djibo, et al. (2007) Meningococcal meningitis: Unprecedented incidence of serogroup X–related cases in 2006 in Niger. Clin. Infect. Dis. 44 657.
15. M. Bone, M. Diver, A. Selby, et al. (2002) Assessment of adrenal function in the initial phase of meningococcal disease. Pediatrics 110 563.
16. A. Boras, D. Bozinovic, F. Tenover, et al. (2001) First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia. J. Clin. Microbiol. 39 823.
17. R. Borrow, H. Joseh, N. Andrews, et al. (2000) Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults. Vaccine 19 1129.
18. P. Brandtzaeg, A. Halstensen, P. Kierulf, et al. (1992) Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microb. Pathog. 13 423-431.
19. P. Brandtzaeg, P. Kierulf, P. Gaustad, et al. (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159 195.
20. P. Brandtzaeg, T.E. Mollnes and P. Kierulf (1989) Complement activation and endotoxin levels in systemic meningococcal disease. J. Infect. Dis. 160 58.
21. R. Brooks, C.W. Woods, D.K. Benjamin Jr., et al. (2006) Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin. Infect. Dis. 43 49.
22. M. Bruce, N. Rosenstein, J. Capparella, et al. (2001) Risk factors for meningococcal disease in college students. J. A. M. A. 286 688.
23. J. Brundage and W. Zollinger (1987) Evolution of Meningococcal Disease Epidemiology in the U.S. Army 1 Boca Raton, FL: CRC Press
24. R. Buchanan and N. Gibbons (Eds) (1974) Bergey's Manual of Determinative Bacteriology Baltimore: Williams & Wilkins 427.
25. K. Cartwright, S. Reilly, D. White, et al. (1992) Early treatment with parenteral penicillin in meningococcal disease. B. M. J. 305 143.
26. K.A. Cartwright, D.M. Jones, A.J. Smith, et al. (1991) Influenza A and meningococcal disease. Lancet 338 554.
27. D.A. Caugant, E.A. Hoiby, P. Magnus, et al. (1994) Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J. Clin. Microbiol. 32 323.
28. Centers for Disease Control and Prevention (1987) Meningococcal disease among travelers returning from Saudi Arabia. M. M. W. R. Morb. Mortal. Wkly. Rep. 36(33), 559.
29. Centers for Disease Control and Prevention (1995) Serogroup B meningococcal disease—Oregon, 1994. M. M. W. R. Morb. Mortal. Wkly. Rep. 44(7), 121.
30. Centers for Disease Control and Prevention (1998) Outbreaks of group B meningococcal disease—Florida, 1995 and 1997. M. M. W. R. Morb. Mortal. Wkly. Rep. 47(39), 833.
31. Centers for Disease Control and Prevention (2001) Summary of Notifiable disease, U.S. 1999. M. M. W. R. Morb. Mortal. Wkly. Rep. 48 1.
32. Centers for Disease Control and Prevention (2005, 2006) Active Bacterial Core Surveillance Report, in Emerging Infections Program Network. Neisseria meningitidis
33. Centers for Disease Control and Prevention (2006) Inadvertent misadministration of meningococcal conjugate vaccine—United States, June-August 2005. M. M. W. R. Morb. Mortal Wkly. Rep. 55(37), 1016.
34. Centers for Disease Control and Prevention (2006) Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, June 2005–September 2006. M. M. W. R. Morb. Mortal. Wkly. Rep. 55(41), 1120.
35. Centers for Disease Control and Prevention (2007) Provisional cases of selected notifiable diseases, United States. M. M. W. R. Morb. Mortal. Wkly. Rep. 55 1389.
36. Centers for Disease Control and Prevention (2008) Emergence of fluoroquinolone-resistent Neisseria meningitidis—Minnesota and North Dakota, 2007-2008. M. M. W. R. Morb. Mortal. Wkly. Rep. 57 173-175.
37. K. Churchwell, M. McManus, P. Kent, et al. (1995) Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia. J. Clin. Apheresis 10 171.
38. R. Cobroft and A. Henderson (1994) Meningococcal purpura fulminans treated with antithrombin III concentrate: What is the optimal replacement therapy? Aust. N. Z. J. Med. 24 575.
39. M.S. Cohen, A.C. Steere, R. Baltimore, et al. (1979) Possible nosocomial transmission of group Y Neisseria meningitidis among oncology patients. Ann. Intern. Med. 91 7.
40. E. Conway and R. Rosenberg (1988) Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell. Biol. 8 5588-5592.
41. E. Cooper, R. Ellison, G. Smith, et al. (1986) Rifampin-resistant meningococcal disease in a contact patient given prophylactic rifampin. J. Pediatr. 108 93.
42. C. Corless, M. Guiver, R. Borrow, et al. (2001) Simultaneous detection of Neisseria meningitidis Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J. Clin. Microbiol. 39 1553.
43. A. Corso, D. Faccone, M. Miranda, et al. (2005) Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina. J. Antimicrob. Chemother. 55 596.
44. L.E. Cuevas, P. Kazembe, G.K. Mughogho, et al. (1995) Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: A comparison of ciprofloxacin and rifampicin. J. Infect. Dis. 171 728.
45. J. Dahle (1983) Pathogenesis of hemorrhagic skin lesions in meningococcal disease. N. I. P. H. Ann. 6 49.
46. R. D'Amelio, A. Agostoni, R. Biselli, et al. (1992) Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy. Scand. J. Immunol. 35 589.
47. C.E. Davis and K. Arnold (1974) Role of meningococcal endotoxin in meningococcal purpura. J. Exp. Med. 140 159.
48. Davis, R.: Guillain-Barré syndrome among recipients of meningococcal conjugate vaccine (Menactra) June 2005–September 2006. Presented at a meeting of the Advisory Committee on Immunization Practices, Atlanta, 2006.
49. E. De Kleign, K. Joosten, B. Van Rijn, et al. (2002) Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr. Infect. Dis. J. 21 330.
50. J.C. de Moraes, B.A. Perkins, M.C. Camargo, et al. (1992) Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil [published erratum appears in Lancet 1992 Dec 19-26;340(8834-8835):1554]. Lancet 340 1074.
51. M. den Brinker, K. Joosten, O. Liem, et al. (2005) Adrenal insufficiency in meningococcal sepsis: Bioavaialable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J. Clin. Endocrinol. Metab. 90 5110.
52. P. Densen, J.M. Weiler, J.M. Griffiss, et al. (1987) Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination. N. Engl. J. Med. 316 922.
53. B. Derkx, J. Wittes and R. McCloskey (1999) Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin in children with meningococcal septic shock. Clin. Infect. Dis. 28 770.
54. I.W. DeVoe and F. Gilka (1976) Disseminated intravascular coagulation in rabbits: Synergistic activity of meningococcal endotoxin and materials egested from leucocytes containing meningococci. J. Med. Microbiol. 9 451.
55. K. Dhodapkar, S. Corbacioglu, M.K. Chang, et al. (2000) Purpura fulminans caused by group A beta-hemolytic Streptococcus sepsis. J. Pediatr. 137 562.
56. R. Dickson, N. McKinnon, D. Magner, et al. (1941) Meningococcal infection. Lancet 2 631.
57. L.M. Dixon and H.S. Sanford (1971) Meningococcal pericarditis in the antibiotic era. Mil. Med. 136 433.
58. W. Dock (1924) Intermittent fever of seven months duration due to meningococcemia. J. A. M. A. 83 399.
59. M.S. Edwards and C.J. Baker (1981) Complications and sequelae of meningococcal infections in children. J. Pediatr. 99 540.
60. B. Eley and M. Levin (1994) Septic shock with special reference to meningococcal disease. Curr. Opin. Infect. Dis. 7 345.
61. J. Ellsworth, M.I. Marks and A. Vose (1979) Meningococcal meningitis in children. C. M. A. J. 120 155.
62. J. Faber, C. Meyer, C. Gemmer, et al. (2006) Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy. Pediatr. Infect. Dis. J. 25 80.
63. J. Faber, T.F. Schuessler, A. Finn, et al. (2007) Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood. Pediatr. Infect. Dis. J. 26 243.
64. Y. Faur, M. Weisburd and M. Wilson (1975) Isolation of Neisseria meningitidis from the genito-urinary tract and. J. Clin. Microbiol. 2 178.
65. I. Feavers (2000) ABC of meningococcal diversity. Nature 404 451.
66. J.E. Figueroa and P. Densen (1991) Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4 359.
67. C. Fijen, E. Kuijper, A. Hannema, et al. (1989) Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet 2 585.
68. M. Fisher, K. Hedberg, P. Cardosi, et al. (1997) Tobacco smoke as a risk factor for meningococcal disease. Pediatr. Infect. Dis. J. 10 979.
69. Food and Drug Administration (2005) Product Approval Information—Licensing Action. U.S. Department of Health and human Services, Food and Drug Administration Center for Biologics Evaluation and Research
70. E. Francke and H. Neu (1981) Postsplenectomy infection. Surg. Clin. North Am. 61 135.
71. C.E. Frasch (1977) Role of protein serotype antigens in protection against disease due to Neisseria meningitidis. J. Infect. Dis. 136(Suppl.), S84.
72. C. Frasch, W. Zollinger and J. Poolman (1985) Serotype antigens of Neisseria meningitidis and a proposed scheme for design of serotypes. Rev. Infect. Dis. 7 504.
73. P. Gardner (2006) Prevention of meningococcal disease. N. Engl. J. Med. 355 1466.
74. P. Gerard, M. Moriau, A. Bachy, et al. (1973) Meningococcal purpura: Report of 19 patients treated with heparin. J. Pediatr. 82 780.
75. A. Gilmore, J. Stuart and N. Andrews (2000) Risk of secondary meningococcal disease in health-care workers. Lancet 356 1654.
76. E. Girardin, G.E. Grau, J.M. Dayer, et al. (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319 397.
77. N. Girgis, Y. Sultan, R.W. Frenck Jr., et al. (1998) Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatr. Infect. Dis. J. 17 816.
78. I. Goldschneider, E.C. Gotschlich and M.S. Artenstein (1969) Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129 1307.
79. I. Goldschneider, E.C. Gotschlich and M.S. Artenstein (1969) Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129 1327.
80. S. Greenfield, P.R. Sheehe and H.A. Feldman (1971) Meningococcal carriage in a population of “normal” families. J. Infect. Dis. 123 67.
81. B.M. Greenwood, A.K. Bradley and R.A. Wall (1985) Meningococcal disease and season in sub-Saharan Africa. Lancet 2 829.
82. B.M. Greenwood, M. Hassan-King and H.C. Whittle (1978) Prevention of secondary cases of meningococcal disease in household contacts by vaccination. B. M. J. 1 1317.
83. B. Greenwood and H. Whittle (1976) The pathogenesis of meningococcal arthritis. D. Dumonde, M. Path (Eds) Infection and Immunology in Rheumatic Diseases Philadelphia: J. B. Lippincott 119.
84. R. Haggerty and M. Zaia (1964) Acute bacterial meningitis. Adv. Pediatr. 13 129.
85. S. Hahné, A. Charlett, B. Purcell, et al. (2006) Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: Systematic review. B. M. J. 332 1299.
86. J. Hardman (1968) Fatal meningococcal infections: The changing pathologic picture in the '60s. Mil. Med. 133 951.
87. L. Harrison, K. Jolley, K. Shutt, et al. (2006) Antigenic shift and increased incidence of meningococcal disease. J. Infect. Dis. 193 1266.
88. C. Hart and T. Rogers (1993) Meningococcal disease. J. Med. Microbiol. 39 3.
89. R. Herman and H. Rubin (1974) Meningococcal pericarditis without meningitis presenting as tamponade. N. Engl. J. Med. 290 143.
90. W. Herrick (1919) Extrameningeal meningococcus infections. Arch. Intern. Med. 23 409.
91. W. Hill and T. Kinney (1947) The cutaneous lesions in acute meningococcemia. A clinical and pathologic study. J. A. M. A. 134 513.
92. B.E. Holbein (1981) Differences in virulence for mice between disease and carrier strains of Neisseria meningitidis. Can. J. Microbiol. 27 738.
93. B. Hubert, L. Watier, P. Garnerin, et al. (1992) Meningococcal disease and influenza-like syndrome: A new approach to an old question. J. Infect. Dis. 166 542.
94. S. Inkelis, D. O'Leary, V. Wang, et al. (2002) Extremity pain and refusal to walk in children with invasive meningococcal disease. Pediatrics 110 e3.
95. J. Irazuzta and M.L. McManus (1990) Use of topically applied nitroglycerin in the treatment of purpura fulminans. J. Pediatr. 117 993.
96. L. Jackson and J. Wenger (1993) Laboratory-based surveillance for meningococcal disease in selected areas: United States, 1989-1991. M. M. W. R. C. D. C. Surveill. Summ. 42(2), 21.
97. L.A. Jackson, A. Schuchat, M.W. Reeves, et al. (1995) Serogroup C meningococcal outbreaks in the United States. An emerging threat. J. A. M. A. 273 383.
98. L.A. Jackson, F.C. Tenover, C. Baker, et al. (1994) Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group. J. Infect. Dis. 169 438.
99. J.A. Jacobson, P.A. Camargos, J.T. Ferreira, et al. (1976) The risk of meningitis among classroom contacts during an epidemic of meningococcal disease. Am. J. Epidemiol. 104 552.
100. R.N. Jones, J. Slepack and A. Eades (1976) Fatal neonatal meningococcal meningitis. Association with maternal cervical-vaginal colonization. J. A. M. A. 236 2652.
101. A. Kaiser, C. Hennekens, M. Saslaw, et al. (1974) Seroepidemiology and chemoprophylaxis of disease due to sulfonamide-resistant Neisseria meningitidis in a civilian population. J. Infect. Dis. 130 217.
102. S. Kaplan, G. Schutze, J. Leake, et al. (2006) Multicenter surveillance of invasive meningococcal infections in children. Pediatrics. 118 4.
103. D. Kaspar, J. Winkelhake and W. Zollinger (1973) Immunochemical similarity between polysaccharide antigens of Escherichia coli 07:K1(L):NM and group B Neisseria meningitidis. J. Immunol. 110 262.
104. B. Kaufman, H. Levy, B. Zaleznak, et al. (1951) Statistical analysis of 242 cases of meningococcus meningitis. Pediatrics 38 705.
105. H. Keyserling, T. Papa, K. Koranyi, et al. (2005) Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents. Arch. Pediatr. Adolesc. Med. 159 907.
106. E. Kirsch, P. Barton, L. Kitchen, et al. (1996) Pathophysiology, treatment and outcome of meningococcemia: A review and recent experience. Pediatr. Infect. Dis. J. 15 967.
107. G. Koppe, E. Ellenbogen and R. Gebhart (1977) Group Y meningococcal disease in United States Air Force recruits. Am. J. Med. 62 661.
108. P. Kozarsky, P. Arguin and A. Navin (2006) Health Information for International Travel 2005-2006 Atlanta: Department of Health and Human Services
109. G. Kravitz, D. Dries, M. Peterson and P.M. Schlievert (2005) Purpura fulminans due to Staphylococcus aureus. Clin. Infect. Dis. 40 941.
110. M. Kunkel, L. Brown, H. Bauta and P.B. Iannini (1984) Meningococcal mesenteric adenitis and peritonitis in a child. Pediatr. Infect. Dis. J. 3 327.
111. N. Kupperman, S. Inkelis and R. Saladino (1994) The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans. Pediatr. Infect. Dis. J. 13 867.
112. J. Leake and B. Perkins (2000) Meningococcal disease: Challenges in prevention and management. Infect. Med. 17 364.
113. F. Leclerc, A. Martinot, R. Cremer and C. Fourier (1997) ECMO for refractory cardiorespiratory failure due to meningococcal disease. Lancet 349 1397.
114. T.J. Lehman, B. Bernstein, V. Hanson, et al. (1981) Meningococcal infection complicating systemic lupus erythematosus. J. Pediatr. 99 94.
115. A. Lehmann, A. Halstensen, S. Sornes, et al. (1995) High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J. Infect. Dis. 171 229.
116. R. Leibel, J. Fangman and M. Ostrovsky (1974) Chronic meningococcemia in childhood. Am. J. Dis. Child. 127 94.
117. M. Levin, P. Quint, B. Goldstein, et al. (2000) Recombinant bactericidal/permeability-increasing protein (rBPI) as adjunctive treatment for children with severe meningococcal sepsis: A randomized trial. Lancet 356 961.
118. L. Levitt, J. Bond, I. Hall Jr., et al. (1970) Meningococcal and ECHO-9 meningitis. Report of an outbreak. Neurology 20 45.
119. J. Lewis, C. Arnold and J. Alexander (1973) Meningococcal pneumonia. Am. J. Clin. Pathol. 59 388.
120. B. Linz, M. Schenker, P. Zhu, et al. (2000) Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis. Mol. Microbiol. 36 1049.
121. J. MacLennan, S. Obaro, J. Deeks, et al. (1999) Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunization during early childhood. Vaccine 17 3086.
122. M.C. Maiden (1993) Population genetics of a transformable bacterium: The influence of horizontal genetic exchange on the biology of Neisseria meningitidis. F. E. M. S. Microbiol. Lett. 112 243.
123. V. Manchanda and P. Bhalla (2006) Emergence of non–ceftriaxone-susceptible Neisseria meningitidis in India. J. Clin. Microbiol. 44 4290.
124. M.I. Marks, C.E. Frasch and R.M. Shapera (1979) Meningococcal colonization and infection in children and their household contacts. Am. J. Epidemiol. 109 563.
125. O. Marzouk, A. Thomson, J. Sills, et al. (1991) Features and outcome in meningococcal disease presenting with maculopapular rash. Arch. Dis. Child. 66 485.
126. M. Mellado, R. Rodriguez-Contreras, A. Mariscal, et al. (1991) Effect of penicillin and chloramphenicol on the growth and endotoxin release by N. meningitidis. Epidemiol. Infect. 106 283.
127. P. Mendelman, J. Campos, D. Chaffin, et al. (1988) Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob. Agents Chemother. 32 706.
128. Meningococcal disease and college students (2000) Recommendations of the Advisory Committee on Immunization Practices (ACIP). M. M. W. R. Recomm. Rep. 49(RR-7), 13.
129. Meningococcal Disease Update 2007. ProMed. Available at http://www.promedmail.org/pls/promed/f?p=2400:1202:10374748748848896256::NO::F2400_P1202_CHECK_DISPLAY,F2400_P1202_PUB_MAIL_ID:X,36797 (accessed April 6, 2007).
130. M. Meyer, J. Irazuzta and H. Tozibikian (1999) Topical nitroglycerin and pain in purpura fulminans. J. Pediatr. 134 639.
131. S. Moncada and E. Higgs (1991) Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21 361.
132. P.S. Moore, L.H. Harrison, E.E. Telzak, et al. (1988) Group A meningococcal carriage in travelers returning from Saudi Arabia. J. A. M. A. 260 2686.
133. P.S. Moore, J. Hierholzer, W. DeWitt, et al. (1990) Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. J. A. M. A. 264 1271.
134. P.S. Moore, M.W. Reeves, B. Schwartz, et al. (1989) Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet 2 260.
135. H.W. Morrow, D.D. Slaten, A.L. Reingold, et al. (1990) Risk factors associated with a school-related outbreak of serogroup C meningococcal disease. Pediatr. Infect. Dis. J. 9 394.
136. J. Morse, M. Oretsky and J. Hudson (1971) Pericarditis as a complication of meningococcal meningitis. Ann. Intern. Med. 74 212.
137. S. Nadel, C. De Munter, J. Britto, et al. (1998) Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans. Crit. Care Med. 26 971.
138. S. Nadel, B. Goldstein, M. Williams, et al. (2007) Drotrecogin alfa (activated) in children with severe sepsis: A multicentre phase III randomized controlled trial. Lancet 369 836.
139. X. Nassif and M. So (1995) Interaction of pathogenic Neisseriae with nonphagocytic cells. Clin. Microbiol. Rev. 8 376.
140. P. Nawroth and D. Stern (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med. 320 1165.
141. H. Ni, A. Knight, K. Cartwright, et al. (1993) Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet 340 1432.
142. H.E. Nielsen, C. Koch, P. Magnussen, et al. (1989) Complement deficiencies in selected groups of patients with meningococcal disease. Scand. J. Infect. Dis. 21 389.
143. P. Niklasson, P. Lundbergh and T. Strandell (1971) Prognostic factors in meningococcal disease. Scand. J. Infect. Dis. 3 17.
144. A. Ognibene and W. Dito (1964) Chronic meningococcemia. Arch. Intern. Med. 114 29.
145. P. Olcen, J. Kjellander, D. Danielsson, et al. (1981) Epidemiology of Neisseria meningitidis; prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand. J. Infect. Dis. 13 105.
146. E. Oppenheimer and N. Rosman (1976) Bacterial meningitis in childhood: Neurologic complications and their management. Pediatr. Neurol. 287 285.
147. J. Parillo (1993) Pathogenic mechanisms of septic shock. N. Engl. J. Med. 328 307.
148. J. Penny, W. Grace and R. Kennedy (1966) Meningococcal pericarditis. Am. J. Cardiol. 18 281.
149. E. Perez-Trallero, L. Aldamiz-Echeverria and E.G. Perez-Yarza (1990) Meningococci with increased resistance to penicillin. Lancet 335 1096.
150. M. Pichichero, J. Casey, M. Blatter, et al. (2005) Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide–diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children. Pediatr. Infect. Dis. J. 24 57.
151. M. Pichichero, T. Papa, M. Blatter, et al. (2006) Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine. Pediatr. Infect. Dis. J. 25 995.
152. R. Pinals and M. Ropes (1964) Meningococcal arthritis. Arthritis Rheum. 7 241.
153. R.W. Pinner, F. Onyango, B.A. Perkins, et al. (1992) Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group. J. Infect. Dis. 166 359.
154. M. Pizzi (1944) A severe epidemic of meningococcus meningitis in Chile, 1941-2. Am. J. Public Health 34 231.
155. A. Platonov, V. Beloborodov and I. Vershinina (1993) Meningococcal disease in patients with late complement deficiency: Studies in the U.S.S.R. Medicine (Baltimore) 72 374.
156. J. Poolman, P. van der Ley and J. Tommassen (1995) Surface Structures and Secreted Products of Meningococci Chichester, UK: Wiley
157. T. Popovic, C.T. Sacchi, M.W. Reeves, et al. (2000) Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg. Infect. Dis. 6 428.
158. D. Powars, R. Larsen, J. Johnson, et al. (1993) Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. Clin. Infect. Dis. 17 254.
159. D. Powars, Z. Rogers, M. Patch, et al. (1987) Purpura fulminans in meningococcemia: Association with acquired deficiencies of proteins C and S. N. Engl. J. Med. 317 571.
160. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). M. M. W. R. Recomm. Rep. 49(RR-7), 1.
161. J. Racoosin, C. Whitney, C. Conover, et al. (1998) Serogroup Y meningococcal disease in Chicago, 1991-1997. J. A. M. A. 280 2094.
162. M. Ramsay, N. Andrews, E. Kaczmarski, et al. (2001) Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357 195.
163. M. Ramsay, N. Andrews, C. Trotter, et al. (2003) Herd immunity from meningococcal serogroup C conjugate vaccination in England: Database analysis. B. M. J. 326 365.
164. R. Read, N. Camp, F. Di Giovine, et al. (2000) An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J. Infect. Dis. 182 1557.
165. F.X. Riedo, B.D. Plikaytis and C.V. Broome (1995) Epidemiology and prevention of meningococcal disease. Pediatr. Infect. Dis. J. 14 643.
166. F. Riordan, A. Thomson, J. Ratcliffe, et al. (1999) Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency? Crit. Care Med. 27 2257.
167. S. Robboy (1972) Atrioventricular node inflammation: Mechanism of sudden death in protracted meningococcemia. N. Engl. J. Med. 286 1091.
168. F. Rodriguez-Erdmann (1965) Intravascular activation of the clotting system with phospholipids. Blood 26 541.
169. Rosenblatt, J., Ray, C., and Enquist, R. W.: Meningococcal infections in children: Observations on prognosis and therapy. Personal Communication, 1978.
170. N.E. Rosenstein and B.A. Perkins (2000) Update on Haemophilus influenzae serotype b and meningococcal vaccines. Pediatr. Clin. North Am. 47 337.
171. N.E. Rosenstein, B.A. Perkins, D.S. Stephens, et al. (1999) The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis. 180 1894.
172. N.E. Rosenstein, B.A. Perkins, D.S. Stephens, et al. (2001) Meningococcal disease. N. Engl. J. Med. 344 1378.
173. S.C. Ross and P. Densen (1984) Complement deficiency states and infection: Epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63 243.
174. J. Saez-Nieto, R. Lujan, S. Berron, et al. (1992) Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: A 5-year history (1985-1989). Clin. Infect. Dis. 1(Suppl.), S12.
175. Sanofi Pasteur (2006) Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine Swiftwater, PA: Sanofi Pasteur 1.
176. A. Scheim (1938) Articular manifestations of meningococcic infections. Arch. Intern. Med. 62 963.
177. R.J. Scholten, H.A. Bijlmer, H. Tobi, et al. (1999) Upper respiratory tract infection, heterologous immunisation and meningococcal disease. J. Med. Microbiol. 48 943.
178. L. Scott, D. Knox, L. Perry, et al. (1972) Meningococcal pericarditis. Am. J. Cardiol. 29 104.
179. J. Sinclair, C. Skeoch and D. Hallworth (1987) Prognosis of meningococcal septicaemia. Lancet 3 38.
180. O. Smith, B. White, D. Vaughn, et al. (1997) Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet 350 1590.
181. B. Spratt, Q. Zhang, D. Jones, et al. (1989) Recruitment of a penicillin-binding protein gene from Neisseria flavescens during the emergence of penicillin-resistant Neisseria meningitidis. Proc. Natl. Acad. Sci. U. S. A. 86 315.
182. R.E. Stanwell-Smith, J.M. Stuart, A.O. Hughes, et al. (1994) Smoking, the environment and meningococcal disease: A case control study. Epidemiol. Infect. 112 315.
183. D. Stephens and M. Farley (1991) Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae. Rev. Infect. Dis. 12 22.
184. D. Stephens, L. Hoffman and Z. McGee (1983) Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: Attachment and entry into columnar epithelial cells. J. Infect. Dis. 148 369.
185. E. Stiehm and D. Damrosch (1966) Factors in the prognosis of meningococcal infection. J. Pediatr. 68 457.
186. J.M. Stuart, K.A. Cartwright, P.M. Robinson, et al. (1989) Effect of smoking on meningococcal carriage. Lancet 2 723.
187. T. Sullivan and L. La Scolea (1987) Neisseria meningitidis bacteremia in children: Quantitation of bacteremia and spontaneous clinical recovery without antibiotic therapy. Pediatrics 80 63.
188. E.M. Sutcliffe, D.M. Jones, S. El-Sheikh, et al. (1988) Penicillin-insensitive meningococci in the UK. Lancet 1 657.
189. J. Swartley, A. Marfin, S. Edupuganti, et al. (1997) Capsule switching of Neisseria meningitidis. Proc. Natl. Acad. Sci. U. S. A. 94 271.
190. A. Thompson, J. Sills and C. Hart (1991) Validation of the Glasgow meningococcal septicacemia prognostic score; a 10-year retrospective survey. Crit. Care Med. 19 26.
191. J. Tobias, S. Haun, M. Helfaer, et al. (1989) Use of continuous caudal block to relieve lower extremity ischemia caused by vasculitis in a child with meningococcemia. J. Pediatr. 115 1019.
192. C. Trotter, N. Andrews, E. Kaczmarski, et al. (2004) Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364 365.
193. J. Tully, R. Viner and P. Coen (2006) Risk and protective factors for meningo-coccal disease in adolescents: Matched cohort study. B. M. J. 332 445.
194. A. Tuncer, I. Gar, U. Ertem, et al. (1988) Once daily ceftriaxone for meningococcemia and meningococcal meningitis. Pediatr. Infect. Dis. J. 7 711.
195. A. van de Ende, C. Hopman and J. Dankert (2000) Multiple mechanism of phase variation of PorA in Neisseria meningitidis. Infect. Immun. 68 6685.
196. J. van der ven-Jongekrijg, J. van der ven-Jongekrijg, P. Demacker, et al. (1994) Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J. Infect. Dis. 169 157.
197. M. van Deuren, J. van der ven-Jongekrijg, A. Bartelink, et al. (1995) Correlation between proinflammatory cytokines and anti-inflammatory mediators and the severity of disease in meningococcal infections. J. Infect. Dis. 172 632.
198. M. van Deuren, B. van Dijke, R.J. Koopman, et al. (1993) Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. B. M. J. 306 1229.
199. W. Vann, T. Liu and J. Robbins (1976) Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide. Infect. Immun. 13 1654.
200. Z. Van Nguyen, E. Nguyen and L. Weiner (1984) Incidence of invasive bacterial disease in children with fever and petechiae. Pediatrics 74 77.
201. G. Vieusseux (1806) Memoire sur la maladie qui a regre a Geneve au printemps de 1805. J. Med. Chir. Pharm. 11 163.
202. U. Vogel, H. Claus and M. Frosch (2000) Rapid serogroup switching in Neisseria meningitidis. J. Med. 342 219.
203. D.M. Vu, J.A. Welsch, P. Zuno-Mitchell, et al. (2006) Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine. J. Infect. Dis. 193 821.
204. N.C. Weightman and D.J. Johnstone (1999) Three cases of pneumonia due to Neisseria meningitidis, including serogroup W135. Eur. J. Clin. Microbiol. Infect. Dis. 18 456.
205. E. Weis and E. Silber (1961) Acute constrictive pericarditis. J. Pediatr. 58 548.
206. R. Westendorp, J. Langermans, C. de Bel, et al. (1995) Release of tumor necrosis factor: An innate host characteristic that may contribute to the outcome of meningococcal disease. J. Infect. Dis. 171 1057.
207. R. Westendorp, J. Langermans, T. Huizinga, et al. (1997) Genetic influence on cytokine production and fatal meningococal disease. Lancet 349 170.
208. H. Whittle, P. Tugwell, L. Egler, et al. (1974) Rapid bacteriologic diagnosis of pyogenic meningitis by latex agglutination. Lancet 2 619.
209. F. Wilson and S. Morse (1972) Therapy of acute meningococcal infections: Early volume expansion and prophylactic low dose heparin. Am. J. Med. Sci. 264 445.
210. W. Winn Jr., S. Allen, W. Janda, et al. (2006) Koneman's Color Atlas and Textbook of Diagnostic Microbiology Baltimore: Lippincott Williams & Wilkins
211. R. Wolf and C. Birbara (1968) Meningococcal infections at an army training center. Am. J. Med. 44 243.
212. S. Wong, D. Lennon, C. Jackson, et al. (2007) New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months. Pediatr. Infect. Dis. J. 26 345.
213. V. Wong, W. Hitchcock and W. Mason (1989) Meningococcal infections in children: A review of 100 cases. Pediatr. Infect. Dis. J. 8 224.
214. L. Young, F. LaForce, J. Head, et al. (1972) A simultaneous outbreak of meningococcal and influenza infections. N. Engl. J. Med. 287 5.
215. K.M. Zangwill, A. Schuchat, F.X. Riedo, et al. (1997) School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis. J. A. M. A. 277 389.
216. Q. Zhang, D. Jones, J. Saez-Nieto, et al. (1990) Genetic diversity of penicillin-binding protein 2 genes of penicillin-resistant strains of Neisseria meningitidis revealed by fingerprinting of amplified DNA. Antimicrob. Agents Chemother. 34 1523.